overview
RADICAVA® (edaravone) is the only FDA-approved treatment option for amyotrophic lateral sclerosis (ALS) in the last 20 years.
Mitsubishi Tanabe Pharma America
RADICAVA® (edaravone) is the only FDA-approved treatment option for amyotrophic lateral sclerosis (ALS) in the last 20 years.
The RX Club 2017 Creative Excellence Award for Healthcare Professional Website
The RX Club 2017 1:1 Product Website